6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 20K1
Book a meeting

Noventure

  • Noventure
About Noventure

Noventure is a portfolio of clinically proven, consumer-facing healthcare brands trusted by healthcare professionals and patients in more than 50 countries. Our mission is to build trust for people all around the world by providing clinically-backed products that offer real relief without harm so they can live healthier, freer lives without fear or doubt in their care. Our brands, including Tasectan, Utipro Plus, and Ulkox, are: Backed by clinical trials, Included in treatment guidelines, CE-marked and MDR Class III compliant, Protected by patents We work with leading pharmaceutical partners worldwide to make our products the number one choice in their therapeutic class.

Read more Show less
Certifications
  • CE
    CE
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 20K1
  • Country/Region:
    Spain
  • Founded:
    2001
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    1 - 24
Company types
Pharmaceutical company
Primary activities
Packaging & drug delivery
Contact info
Show contact info Hide contact info

Products from Noventure (3)

  • Tasectan® AF

    Product Tasectan® AF

    Tasectan® AF is a substance-based medical device composed of xyloglucan (tamarind seed extract) and gelose. This combination acts by forming a film that protects the intestinal mucosa, reducing the frequency and duration of diarrhoeal episodes. The therapeutic effects of the device start from 6 hours after...
  • Tasectan® AF Kids

    Product Tasectan® AF Kids

    Tasectan® AF is a substance-based medical device composed of xyloglucan (tamarind seed extract) and gelose. This combination acts by forming a film that protects the intestinal mucosa, reducing the frequency and duration of diarrhoeal episodes. The therapeutic effects of the device start from 6 hours after...
  • Utipro® Plus AF

    Product Utipro® Plus AF

    Utipro® Plus AF is a medical device based on xyloglucan and gelose.

    It acts mechanically in the intestinal lumen, impairing the contact of the pathogens with the intestinal mucosa, which is the first step for bacterial proliferation and their subsequent passage to the urinary tract.

Noventure Resources (2)